Technology News and Research

RSS

Viewpoints: Chambliss on reviving Gang of Six proposal; WSJ on Medicare Part D; Friedman on 'doing this right'

I joined five other senators to identify the difficult issues and make the hard, necessary decisions to address the twin challenges of our deficit and debt. ... Among other provisions, our proposal reduces the debt by $3.7 trillion over the next 10 years, stabilizes our publicly held debt by 2014, and imposes tough and honest budget enforcement.

28 Jul 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

Epitomics launches 23 novel cancer-related antibodies

Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal technology, today announced the Company has now launched 23 novel cancer-related antibodies that were developed through a partnership with the National Cancer Institute's Center for Cancer Research.

27 Jul 2011

Dow second quarter sales increase to $16.0 billion

Dow reported earnings of $0.84 per share. This compares with reported earnings of $0.50 per share in the same period last year.

27 Jul 2011

Teleflex second quarter net revenues increase 9.2% to $391.3 million

Teleflex Incorporated today announced financial results for the second quarter and six months ended June 26, 2011.

27 Jul 2011

TMS rolls out MUNI for law enforcement and other government agencies

Total Medical Solutions (TMS), specializing in complex care for workers' compensation, has rolled out MUNI for municipalities, law enforcement and other government agencies.

27 Jul 2011

Underwater-treadmill improves mobility following spinal-cord injury

The result of research often is shown in hard and fast metrics. For Janette Rodgers, the only metric she cares about is that her wheelchair, once her prison day in and day out, now sits empty 90 percent of the time— in large part because of the hours she spent in 270 gallons of water.

27 Jul 2011

Study reveals several compounds that block cancer cell invasion

Metastasis-the spread of cancer from the place where it first started to another place in the body-is the most common reason that cancer treatments fail. To metastasize, some types of cancer cells rely on invadopodia, cellular membrane projections that act like feet, helping them "walk" away from the primary tumor and invade surrounding tissues.

27 Jul 2011

Positive results from phase Ib/IIa trial of novel molecular technique for Duchenne muscular dystrophy

A molecular technique originally developed at the University of North Carolina at Chapel Hill has taken one step closer to becoming a treatment for the devastating genetic disease Duchenne muscular dystrophy.

27 Jul 2011

UBC research projects receive CIHR grants to promote greater equity in global health

Three research projects at the University of British Columbia have won five-year grants totaling nearly $6 million from the Canadian Institutes of Health Research (CIHR) to promote greater equity in global health.

27 Jul 2011

New convenient device can track degenerative eye disease

An ophthalmologist at UT Southwestern Medical Center has helped create a convenient device that lets patients who have a degenerative eye disease better track vision changes.

27 Jul 2011

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a pinball machine.

27 Jul 2011

Innovative MD leadership program for medical students

The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.

27 Jul 2011

Special panel votes in favor of HDE approval for EXCOR Pediatric VAD

At the request of Dr. Bram Zuckerman, Director, Division of Cardiovascular Devices, Center for Devices and Radiologic Health of the United States Food and Drug Administration, a special panel was convened on Thursday July 21 in Gaithersburg, Maryland to review the results of the EXCOR® IDE clinical trial.

27 Jul 2011

Roundup: Md. to release cancer control plan; funding cut at Texas mental health centers

Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.

27 Jul 2011

Ceridia completes CER006 Phase 1 Proof-of-Concept study in humans

Ceridia Pty Ltd., a biotechnology company focused on reformulating and developing therapeutic drugs, announce the successful completion of Phase 1 Proof-of-Concept study of its novel LipoCeramic ibuprofen formulation, CER006.

27 Jul 2011

NSU, Immunotec collaborate to determine effects of Immunocal on children with ASD

Immunotec Inc. announces that Nova Southeastern University (NSU) in Florida is conducting a study to determine the effects of Immunocal on the behaviours of children with autism spectrum disorder.

27 Jul 2011

FDA clears ArthroCare's SpeedFix Suture System

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedFix Suture System.

27 Jul 2011

Selexis, CSL enter commercial license agreement for therapeutic antibody

Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.

26 Jul 2011

Kadmon, Dyax enter license agreement for antibody phage display libraries

Dyax Corp. and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax's proprietary "gold-standard" antibody phage display libraries for the discovery and development of therapeutic antibodies.

26 Jul 2011

Technology News and Research

Viewpoints: Chambliss on reviving Gang of Six proposal; WSJ on Medicare Part D; Friedman on 'doing this right'

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Epitomics launches 23 novel cancer-related antibodies

Dow second quarter sales increase to $16.0 billion

Teleflex second quarter net revenues increase 9.2% to $391.3 million

TMS rolls out MUNI for law enforcement and other government agencies

Underwater-treadmill improves mobility following spinal-cord injury

Study reveals several compounds that block cancer cell invasion

Positive results from phase Ib/IIa trial of novel molecular technique for Duchenne muscular dystrophy

UBC research projects receive CIHR grants to promote greater equity in global health

New convenient device can track degenerative eye disease

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

Innovative MD leadership program for medical students

Special panel votes in favor of HDE approval for EXCOR Pediatric VAD

Roundup: Md. to release cancer control plan; funding cut at Texas mental health centers

Ceridia completes CER006 Phase 1 Proof-of-Concept study in humans

NSU, Immunotec collaborate to determine effects of Immunocal on children with ASD

FDA clears ArthroCare's SpeedFix Suture System

Selexis, CSL enter commercial license agreement for therapeutic antibody

Kadmon, Dyax enter license agreement for antibody phage display libraries

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News